Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma

May 10, 2018Scientific reports

Changes in Cell Movement, Growth, and Energy Use in New Models of Brain Tumors Resistant to Temozolomide

AI simplified

Abstract

Two new glioblastoma cell lines resistant to were created and characterized.

  • Acquisition of temozolomide resistance is associated with increased cell proliferation and migration.
  • TMZ resistant variants exhibit chromosomal abnormalities and elevated secretion of cytosolic lipids.
  • Each resistant model reflects distinct aspects of glioblastoma behavior, termed the 'go' and 'grow' hypotheses.
  • These in vitro models enhance the toolkit for studying the molecular mechanisms behind acquired temozolomide resistance.

AI simplified

Key numbers

74%
Increase in G2/M Arrest
G2/M arrest increase in 42MBGA-WT vs. 42MBGA-TMZres cells.
96%
Chromosome Copy Number Increase
42MBGA-TMZres cells with three or more copies of the X chromosome.

Full Text

What this is

  • This research develops two new glioblastoma (GBM) cell lines resistant to (), a common treatment.
  • These models help investigate the mechanisms behind acquired resistance, which severely limits treatment efficacy.
  • The study reveals distinct phenotypic changes in the resistant cell lines, including increased proliferation and migration.

Essence

  • Two novel GBM cell lines resistant to were created, revealing significant changes in cell motility, proliferation, and metabolism. These models provide valuable tools for studying the mechanisms of resistance.

Key takeaways

  • The 42MGBA-TMZres cell line exhibited increased growth, while the 8MGBA-TMZres line showed heightened migration. This supports the 'go or grow' hypothesis in GBM behavior.
  • Both resistant cell lines gained expression of the protein, which is linked to reduced sensitivity to and BCNU, the previous standard of care for GBM.
  • Acquired resistance was associated with increased nuclear size and chromosome number, indicating potential mechanisms of genomic instability in resistant GBM cells.

Caveats

  • The models are in vitro and may not fully replicate the complex tumor microenvironment of GBM in patients. Further studies are needed to validate findings in vivo.
  • Variability in the response to BCNU among the resistant cell lines suggests that additional factors may influence treatment outcomes in clinical settings.

Definitions

  • temozolomide (TMZ): A chemotherapy drug used as a standard treatment for glioblastoma, which can lead to rapid development of resistance.
  • MGMT: O6-methylguanine methyltransferase, a DNA repair protein that removes adducts caused by TMZ, influencing treatment resistance.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free